Independent product information • Affiliate-supported • Last updated
Independent EndoPeak research

Chrysin: Evidence, Absorption & Research Limitations

Chrysin is a good example of why laboratory mechanisms and supplement marketing should not be treated as proof of a human hormone effect.

Reviewed and updated: September 12, 2026
EndoPeak label 50 mg per EndoPeak serving. Independent research This guide discusses the ingredient literature separately from the finished product.

What chrysin is

Chrysin is a naturally occurring flavonoid. EndoPeak lists 50 mg of chrysin and identifies Oroxylum indicum on the current label.

Chrysin is often promoted in testosterone-oriented supplements because of biochemical ideas developed from nonclinical research.

Oral bioavailability is a major issue

Human disposition research has reported low systemic availability after oral chrysin, which complicates the leap from in-vitro mechanisms to real-world supplementation.

If little of a compound reaches circulation unchanged, laboratory concentrations may not reflect what the body experiences after a typical oral dose.

Human testosterone evidence does not support a simple promise

A small human study of a chrysin-containing preparation did not find a change in urinary testosterone. That study does not settle every question about chrysin, but it shows why strong hormone claims need direct human evidence.

EndoPeak therefore does not call the product a proven testosterone booster based on chrysin.

How to read chrysin marketing

Treat phrases such as “aromatase blocker” or “testosterone enhancer” as hypotheses or marketing unless supported by relevant human clinical data at a comparable dose and formulation.

The more appropriate role of this ingredient page is to show the evidence limitations clearly.

Finished-product boundary: Ingredient research does not prove that the complete EndoPeak formula produces the same effects. We did not identify a peer-reviewed randomized controlled trial of the finished EndoPeak formula during this build.

References

  1. Chrysin disposition in humans — Human pharmacokinetic research.
  2. Chrysin-containing preparation and urinary testosterone — Small human study.
  3. Testosterone booster systematic review — Broader evidence context.